Voloridge Investment Management, LLC I Teos Therapeutics, Inc. Transaction History

Voloridge Investment Management, LLC

  • $26.2 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023
SELL
$13.02 - $22.62 $569,481 - $989,376
-43,739 Reduced 78.54%
11,952 $162,000
Q4 2022

Feb 14, 2023
SELL
$17.77 - $21.6 $822,040 - $999,216
-46,260 Reduced 45.37%
55,691 $1.09 Million
Q3 2022

Nov 14, 2022
BUY
$18.6 - $27.25 $316,497 - $463,686
17,016 Added 20.03%
101,951 $1.94 Million
Q2 2022

Aug 15, 2022
SELL
$16.57 - $35.1 $227,837 - $482,625
-13,750 Reduced 13.93%
84,935 $1.75 Million
Q1 2022

May 16, 2022
BUY
$31.92 - $47.45 $3.15 Million - $4.68 Million
98,685 New
98,685 $3.18 Million

Others Institutions Holding ITOS

# of Institutions
166
Shares Held
36.6M
Call Options Held
1.95M
Put Options Held
374K
View Full List

About iTeos Therapeutics, Inc.

ITOS Quotes by TradingView
  • Ticker ITOS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 35,575,300
  • Market Cap $257M
  • Description
  • Iteos Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of immuno-oncology therapeutics for patients. The company's product pipeline includes inupadenant, a small molecule antagonist of the adenosine A2AR antagonists that is in Phase 2 clinical trials; and EOS-448, an antagonist of TIGIT or ...
More about ITOS
Track This Portfolio

Track Voloridge Investment Management, LLC Portfolio

Follow Voloridge Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Voloridge Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voloridge Investment Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email